Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 15:6:1495849.
doi: 10.3389/fcdhc.2025.1495849. eCollection 2025.

Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review

Mohamed Belhadj  1 , Rachid Malek  2 , Houssem Baghous  3 , Mourad Boukheloua  4 , Zakia Arbouche  5 , Nassim Nouri  6 , Mohammed El Amine Amani  1 , Fethia Sersoub  7 , Mohamed Amine Haireche  8
Affiliations
Review

Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review

Mohamed Belhadj et al. Front Clin Diabetes Healthc. .

Abstract

Background: The health and economic impacts of type 2 diabetes mellitus (T2DM) remain substantial, notably in developing countries.

Objectives: To provide an in-depth assessment of the T2DM situation in Algeria to understand its multifaceted burden and identify priority areas of intervention.

Methods: A systematic literature search was conducted on all published articles about T2DM in Algeria over the past 30 years, including original research, reviews, and case series. The extracted data were thoroughly analyzed and synthesized by a committee of diabetes experts.

Results: Algerian epidemiological data point towards a constant rise of T2DM prevalence, roughly from 8.9% in 2003 to 14.4% in 2016-2017. The mean onset is around 41 years with women experiencing a greater burden at younger age. Low socioeconomic status, limited education, and lack of health insurance exacerbate T2DM risk and health inequities. Lifestyle and metabolic risk factors are prevalent. Despite advancements in glycemic control, prescribing practices lack standardization, with suboptimal use of antidiabetic drugs and absence of novel drugs in the market. Health and economic burdens are dominated by complications, highlighting inadequate primary and tertiary prevention strategies.

Conclusion: Notwithstanding the increasing burden of T2DM in Algeria, the healthcare strategies and therapeutic outcomes remain suboptimal. This underscores the necessity for a comprehensive strategy including enhanced prevention, access to novel treatments, standardized practices, along with a patient-centered approach.

Keywords: Algeria; burden; epidemiology; management strategy; prevention; socioeconomic factors; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

FS was employed by Hikma Pharma. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Prevalence of type 2 diabetes in Algeria between 1990-2020 using various estimates and data sources.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J. Epidemiol. Glob Health. (2019) 10:107. doi: 10.2991/jegh.k.191028.001 - DOI - PMC - PubMed
    1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. (2022) 183:109119. doi: 10.1016/j.diabres.2021.109119 - DOI - PMC - PubMed
    1. Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJM, et al. . Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories 1990-2019: results from the global burden of disease study 2019. Front. Endocrinol. (Lausanne). (2022) 13:838027. doi: 10.3389/fendo.2022.838027 - DOI - PMC - PubMed
    1. Chaturvedi N. The burden of diabetes and its complications: Trends and implications for intervention. Diabetes Res. Clin. Pract. (2007) 76:S3–S12. doi: 10.1016/j.diabres.2007.01.019 - DOI - PubMed
    1. Yahagi K, Kolodgie FD, Lutter C, Mori H, Romero ME, Finn AV, et al. . Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. (2017) 37:191–204. doi: 10.1161/ATVBAHA.116.306256 - DOI - PMC - PubMed

LinkOut - more resources